Entities / Company
Alaunos Therapeutics.
immuno-oncology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 7
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Alaunos Therapeutics this week
News at the entities that move Alaunos Therapeutics most-
MarketBeat StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Alaunos Therapeutics
-
Securities and Exchange Commission StructuralBlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Moves Alaunos Therapeutics
-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Alaunos Therapeutics
-
Nasdaq StructuralAppLovin stock is traded on Nasdaq, and both AppLovin and Trade Desk operate in the competitive digital advertising technology landscape.Moves Alaunos Therapeutics
Connections
The 4 strongest of 7, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Alaunos Therapeutics is formally listed on the Nasdaq stock exchange.
-
SEC Structural
Alaunos Therapeutics operates under the formal oversight and reporting requirements of the U.S. Securities and Exchange Commission.
-
MarketBeat Structural
MarketBeat provides consensus rating data for Alaunos Therapeutics.
-
Securities and Exchange Commission Structural
Alaunos Therapeutics is subject to formal regulatory requirements, filing its holdings with the Securities and Exchange Commission.